{
  "author": {
    "name": "Pat Wechsler Alex Nussbaum Bloomberg",
    "webUrl": "/author/profile/pat-wechsler-alex-nussbaum-bloomberg/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 2,
    "social": [],
    "articles": [
      {
        "uri": "/2011/05/18/generics-may-limit-growth-in-drug-spending/",
        "title": "Generics May Limit Growth in Drug Spending",
        "byline": " Pat Wechsler, Alex Nussbaum, Bloomberg ",
        "kicker": "News",
        "prettyDate": "May 18, 2011",
        "timeToRead": "3 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/pat-wechsler-alex-nussbaum-bloomberg/",
            "name": "Pat Wechsler, Alex Nussbaum, Bloomberg"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Expiring patents mean $98 billion in savings for health plans, insurers",
        "body": null
      },
      {
        "uri": "/2011/05/18/generics-may-limit-growth-in-drug-spending/",
        "title": "Generics May Limit Growth in Drug Spending",
        "byline": "Pat Wechsler, Alex Nussbaum, Bloomberg",
        "kicker": "News",
        "prettyDate": "May 18, 2011",
        "timeToRead": "3 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/pat-wechsler-alex-nussbaum-bloomberg/",
            "name": "Pat Wechsler, Alex Nussbaum, Bloomberg"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Expiring patents mean $98 billion in savings for health plans, insurers",
        "body": null
      }
    ]
  }
}